Clinical Trials Arena on MSN
Participant enrolment and retention key to clinical trial derisking
With rising complexity in clinical trials creating additional patient burden, innovative solutions can be leveraged to mitigate risk.
Felicione is an independent clinical research scientist and principal investigator. Walk into any drugstore, natural market, or Costco and you’ll find a dazzling array of supplements promising ...
Clinical trials are the irreplaceable engine of drug development and a bedrock of modern medicine, yet patient enrollment ...
The infectious disease Lassa fever can be fatal, and there is a lack of treatment options with proven efficacy. Researchers ...
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C., May 15, 2026--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced that the U.S. Food and Drug ...
An FDA initiative to implement real-time clinical trials could dramatically accelerate the pace at which new treatments ...
Despite being a cornerstone of cancer treatment advancement, clinical trials remain inaccessible for many patients because of structural, socioeconomic, and systemic barriers. In this ...
Known as seeding trials, these studies prioritize marketing over science while disguising their commercial purpose as legitimate research. Pharmaceutical companies use them to familiarize physicians ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results